Silicon & Software Systems (S3) Announces 90nm CMOS IP Licensing Agreement for Mobile TV Applications
Abilis Systems is the first fabless semiconductor company to propose a single-chip mobile TV solution, integrating both the RF tuner and the demodulator on a 90nm RF CMOS process. Such a device ideally meets the requirements of the cellular phone, portable media player and laptop PC markets.
"S3 is a world leading provider of mixed signal IP with a proven track record in advanced CMOS processes,” said Alain Duret, Abilis chief technology officer. “We chose S3 to provide us with a low power converter solution because of their extensive experience, highly skilled team and their ability to meet our highly challenging objectives in a very tight timeframe. With this agreement, we can integrate best-in-class ADCs in our SoCs, while focusing our resources on our core expertise, namely RF CMOS front-ends and multi-core DSP architectures."
"S3's comprehensive portfolio of mixed-signal IP and design solutions delivers power-efficient single-chip systems for clients developing SoCs at the 90nm and 65nm technology nodes,” said Mike Murray, S3 Mixed-Signal IP Business Manager. “Abilis is an innovative leader for single chip mobile TV solutions, which are ideal applications for S3's 90nm IP.”
S3 delivers world-class innovation in IP integration to reduce design risk and accelerate time-to-revenue for its global client base. The company’s high performance solutions are particularly suited to DVB-H, T, S, WiMAX and WiLAN applications.
About Silicon & Software Systems Ltd. (S3)
S3 is a consumer electronics design company focused on the home entertainment, mobile multimedia and consumer healthcare markets. The company designs integrated circuits and embedded software solutions for its worldwide client base. S3’s comprehensive portfolio of mixed-signal IP and design solutions delivers power-efficient single chip systems for clients developing SoCs at the 90nm and 65nm technology nodes. S3’s clients achieve accelerated time-to-revenue and reduced design risk, benefiting from over twenty years of successful, leading-edge IC development.
For more information, please visit www.s3group.com.
About Abilis Systems
Abilis Systems (www.abiliss.com) is a fabless semiconductor company, founded in 2004 by a team of former Motorola SPS employees. Abilis Systems develops single chip CMOS solutions for OFDM-based radio communication standards, including mobile TV receivers and high speed internet access transceivers and actively cooperates with Nagravision to propose more secure and fully featured conditional access solutions to mobile TV operators. Since 2005, Abilis Systems is a member of the Kudelski Group (www.nagra.com) a world leader in digital security technology. The Kudelski Group is traded on the Swiss Stock Exchange (SWX “KUD”).
|
Related News
- Silicon & Software Systems (S3) to provide DVB-H Software for Philips TV-on-Mobile Solution
- S3 Group and Siano Mobile Silicon Collaborate on Mobile TV Receiver Chips
- Garmin licenses S3's onHandTV Mobile TV Software
- Abilis Systems Ships World's First Production DVB-T 90nm CMOS "Single-Die" Mobile Digital TV Receiver
- Silicon & Software Systems (S3) Introduces 90nm IP Portfolio for Consumer and Enterprise Networking Applications
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |